Citation 183208

WONG,SM: ANTUS,S: GOTTSEGEN,A: FESSLER,B: RAO,GS: SONNENBICHLER,J: WAGNER,H:. (1988). WEDELOLACTONE AND COUMESTAN DERIVATIVES AS A ANTIHEPATOTOXIC AND ANTIPHLOGISTIC PRINCIPLES.. 38(5)

Citation Details

Title	WEDELOLACTONE AND COUMESTAN DERIVATIVES AS A ANTIHEPATOTOXIC AND ANTIPHLOGISTIC PRINCIPLES.
Authors	WONG,SM: ANTUS,S: GOTTSEGEN,A: FESSLER,B: RAO,GS: SONNENBICHLER,J: WAGNER,H:
Year	1988
Volume	38
Issue	5

Summary

Year: 1988

Journal: Unknown

Organisms and Their Experiments (7)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SILYBIN	ACTIVE
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SILYBIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ACUMINATIN	ACTIVE
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ACUMINATIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTED	COUMESTAN,7-11-12-TRIHYDROXY:	None
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,7-11-12-TRIHYDROXY:	ACTIVE
3	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,7-11-12-TRIHYDROXY:	ACTIVE
4	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTAN,7-11-12-TRIHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTED	COUMESTAN,11-12-DIHYDROXY-5-7-DIMETHOXY:	None
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,11-12-DIHYDROXY-5-7-DIMETHOXY:	ACTIVE
3	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,11-12-DIHYDROXY-5-7-DIMETHOXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTED	COUMESTAN,7-ETHOXY-5-11-12-TRIHYDROXY:	None
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,7-ETHOXY-5-11-12-TRIHYDROXY:	ACTIVE
3	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,7-ETHOXY-5-11-12-TRIHYDROXY:	ACTIVE
4	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,7-ETHOXY-5-11-12-TRIHYDROXY:	ACTIVE
5	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTAN,7-ETHOXY-5-11-12-TRIHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTED	COUMESTAN,5-7-11-12-TETRAHYDROXY:	None
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,5-7-11-12-TETRAHYDROXY:	ACTIVE
3	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,5-7-11-12-TETRAHYDROXY:	ACTIVE
4	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	COUMESTAN,5-7-11-12-TETRAHYDROXY:	ACTIVE
5	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTAN,5-7-11-12-TETRAHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORCOMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTED	WEDELOLACTONE	None
2	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	WEDELOLACTONE	ACTIVE
3	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	WEDELOLACTONE	ACTIVE
4	ANTIHEPATOTOXIC ACTIVITY	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	WEDELOLACTONE	ACTIVE
5	LIPOXYGENASE,5: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WEDELOLACTONE	ACTIVE
6	RNA SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	WEDELOLACTONE	ACTIVE

Show SPARQL Queries (1)